Santa Fe BioLabs Develops Optimized and Selective Media for the Pathogenic Yeast Candida auris and is Awarded Wide-Ranging Patent for Design of Selective Microbial Media

Santa Fe BioLabs Develops Optimized and Selective Media for the Pathogenic Yeast Candida auris and is Awarded Wide-Ranging Patent for Design of Selective Microbial Media

Santa Fe BioLabs concluded development of ReCand, a medium for optimized colony formation of dry Candida auris, and AuriFind, a medium for identification by selective growth of viable Candida auris. A patent has been granted for media development based on the underlying principle of modulation of toxicity by quaternary ammonium compounds. - February 16, 2023 - Santa Fe BioLabs LLC

Creative Biolabs Updated Solutions to Support the Intensive Research on Exosomes

A recent market report reveals the huge potential of exosome research, which is gaining mounting research fever across the industry. - February 11, 2023 - Creative Biolabs

Arbor Hemp and Global Healthcare Ambassador Mieko Perez Launch "Arbor by Mieko Perez" Clinically Studied Product Line

Arbor Hemp and Global Healthcare Ambassador Mieko Perez Launch "Arbor by Mieko Perez" Clinically Studied Product Line

Globally recognized healthcare ambassador brings more than a decade of experience in support of consumer buyer trends and product knowledge to Arbor Hemp for her own clinical studied product line. - February 10, 2023 - Arbor Hemp

iTech Announces RCM Services Partnership with EllipseIntel for Gastroenterology / ASC Market

iTech Workshop, a leading provider of secure, cloud-based Medical Billing & Practice Management Software and RCM Services, has announced a strategic partnership with EllipseIntel Solutions. - February 10, 2023 - expEDIum

Former FDA Investigator Launches cGMP Quality Systems Certification

Former FDA Investigator Launches cGMP Quality Systems Certification

With increased actions against pharmaceutical companies, a former FDA Investigator has launched an auditing service to certify any or all of the Quality systems reviewed during FDA inspections. The audits must be on-site and conclude without any Major or Critical observations in order to receive a certificate for the system(s) observed. - February 09, 2023 - FD-AID, LLC

Ocean View Primary Care Wins Hearts in Delmarva

Ocean View Primary Care Wins Hearts in Delmarva

Ocean View Primary Care provides services such as adult primary care, pediatrics, preventative care, immunization, nutrition counseling and laboratory testing. In collaboration with Cardiac Medical Services, Inc. it also utilizes the latest advancements in cardiac technology to evaluate and assess a patient's cardiac health. The open-access practice model allows for same-day appointments for acute and same-day after-hours calls for all types of care. - February 08, 2023 - Cardiac Medical Services, Inc.

DistillerSR Launches Industry's Most Comprehensive and Configurable PRISMA 2020 Flow Diagram Reporting Module

DistillerSR® Inc., the market leader in AI-enabled literature review automation software and creator of DistillerSR™, today announced the launch of full support for the PRISMA 2020 report guidelines. DistillerSR’s PRISMA 2020 flow diagram reporting module enables research... - January 31, 2023 - DistillerSR

Ascend Imaging Center in Southfield, Michigan is Offering Free Calcium Score in Honor of February's "American Heart Month"

Ascend Imaging Center in Southfield, Michigan is Offering Free Calcium Score in Honor of February's "American Heart Month"

Ascend Imaging is offering a Free Calcium Score in honor of American Heart Month for the Month of February, leveraging the latest Artificial Intelligence and technology for the 21st century for the nation's #1 killer, heart attacks. - January 31, 2023 - Ascend Imaging Center

Careington Proud to Sponsor 13th Annual Dr. Martin Luther King Jr. Essay and Oration Scholarship Competition

Careington is proud to have served another year as a "Dream" level sponsor for the 13th annual Dr. Martin Luther King Jr. Essay and Oration Scholarship competition. This annual event is hosted by Linking Cultures of Frisco, a Frisco-based non-profit organization with a mission to connect... - January 29, 2023 - Careington

TSEP Receives a $50K Grant from Google to Address the Lack of Diversity in the Tech Industry Through Culturally Relevant STEM Pipeline Programs

TSEP Receives a $50K Grant from Google to Address the Lack of Diversity in the Tech Industry Through Culturally Relevant STEM Pipeline Programs

The Social Engineering Project (TSEP), a STEM nonprofit organization designed to address the lack of diversity in the tech industry, has received a $50,000 grant from Google’s Global Data Center RISE program to motivate and inspire underrepresented students of color to pursue technical careers. - January 25, 2023 - The Social Engineering Project, Inc.

Zifo R&D Solutions Announces Acquisition of beyontics GmbH

Zifo, a leading global specialist scientific informatics services provider, announces the acquisition of beyontics™. A scientific service provider, beyontics has extensive experience in selecting, configuring, optimizing, and supporting Chromatography Data Systems (CDS), particularly the... - January 19, 2023 - Zifo

Genesis AEC Celebrates 25th Anniversary

Leading AEC firm’s milestone includes 8,300+ projects for 600+ life sciences leaders nationwide. - January 18, 2023 - Genesis AEC

David Joseph Joins XeroThera as President

XeroThera, Inc, a privately held biomaterials and med tech company, developing breakthrough technologies for tissue engineering and the controlled and targeted delivery of drugs and biological molecules, today announced that David S. Joseph has joined the company as President. He is also joining... - January 18, 2023 - XeroThera

Hemanext Partners with the Miami Chapter of the Sickle Cell Disease Association of America to Support Local Sickle Cell Disease Community

Partnership Will Expand to Include Educational and Donation Event with OneBlood. - January 17, 2023 - Hemanext

Newly Available Horse-Side IgG Test Requires No Refrigeration

Newly Available Horse-Side IgG Test Requires No Refrigeration

VMRD, Inc is excited to share the launch of their latest offering for equine veterinarians, a novel horse-side test to measure IgG in foals. - January 17, 2023 - VMRD, Inc.

NooIQ™: Premium "Min-Stim" Nootropic Adaptogen Supplement Stack for Memory and Learning

NooIQ™: Premium "Min-Stim" Nootropic Adaptogen Supplement Stack for Memory and Learning

NooIQ™ is a premium nootropic multi-supplement capsule based on an exhaustive literature review and 7 years of rigorous R&D. Ingredients such as Choline (CDP and Bitartrate) and Magnesium (Citrate and L-threonate) are often associated with improved memory and learning. Others such as L-theanine support concentration and focus while avoiding the excess stimulants found in nervous-energy producing products such as energy shots, as per the manufacturer's minimally-stimulant ("Min-Stim") philosophy. - January 14, 2023 - Integrity Nootropics

Virb Lands New Contract; Expands Its Offerings to Asias with $10B Life Science Company

Virb Lands New Contract; Expands Its Offerings to Asias with $10B Life Science Company

Virb has grown outside the US, now servicing contracts in India and Japan with new client. - January 11, 2023 - Virb

End the Legacy, Dedicated to Providing Resources to and Advocating for the Genetic ALS and FTD Community, Presenting to FDA January 12

End the Legacy, Dedicated to Providing Resources to and Advocating for the Genetic ALS and FTD Community, Presenting to FDA January 12

Individuals impacted by hereditary ALS and FTD announce the establishment of a nonprofit organization dedicated to supporting and advocating for their community, Genetic ALS & FTD: End the Legacy. ALS and FTD are neurodegenerative diseases. ALS affects the motor system and leads to rapidly... - January 10, 2023 - Genetic ALS & FTD: End the Legacy

Huntington Study Group Names First Chief Innovation Officer

Huntington Study Group Names First Chief Innovation Officer

The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, today announced Brett Kinsler has been named to the newly created position of Chief Innovation Officer (CINO). - January 10, 2023 - Huntington Study Group

Creative Diagnostics Introduces New Hemagglutination Inhibition Assay Services

Creative Diagnostics recently introduced Hemagglutination Inhibition Assay services to determine relative concentrations of viruses, bacteria, or antibodies. - January 06, 2023 - Creative Diagnostics

Creative Diagnostics Expands Its Monoclonal Antibodies Offering to Customers

Creative Diagnostics expanded its monoclonal antibodies capabilities and offerings to global customers. - January 06, 2023 - Creative Diagnostics

The MedServ Group Hosts a Health Care Heroes Campaign

The MedServ Group Hosts a Health Care Heroes Campaign

Every day people encounter healthcare heroes who go above and beyond the call of duty to make a difference in the lives of patients. Tell a personal story about a health care hero who will be nominated to win. - January 05, 2023 - The MedServ Group

David Roh Joins AeroGo, Inc. as Western Regional Sales Manager

David Roh Joins AeroGo, Inc. as Western Regional Sales Manager

AeroGo, Inc. is pleased to announce that David Roh has joined the firm as Western Regional Sales Manager. David will manage business relationships and dealer development throughout the western half of the United States and Canada. David will focus on flexible manufacturing solutions and provide... - January 03, 2023 - AeroGo, Inc.

MAKO Medical Expands Popular ASPT-Accredited Phlebotomy Program

MAKO Medical Expands Popular ASPT-Accredited Phlebotomy Program

Mako Medical and Mako Medical Laboratories expands accredited phlebotomy school to develop and train new students. - December 31, 2022 - Mako Medical Laboratories

Nisha Johari, MD & Co-Founder, JDHL Featured as "Most Influential Business-Woman of the Year 2022"

Mrs Nisha Johari, MD & Co-founder of Johari Digital Healthcare Ltd. has been featured as "The Most Influential Business Women of the Year 2022,” by The CEO Magazine. - December 31, 2022 - Johari Digital Healthcare Ltd.

The Alliance, Powered by Mako Medical, Expands Into New Jersey

The Alliance, Powered by Mako Medical, Expands Into New Jersey

Mako Medical expands its presence into New Jersey. The Alliance is a national network of laboratories that are coming together to form one lf the largest labs in America. - December 30, 2022 - Mako Medical Laboratories

Mako Medical Donates $25,000 to Help Families for Christmas

Mako Medical Donates $25,000 to Help Families for Christmas

Mako Medical and CEO Chad Price team up with Erica Delong at G105 Radio to help families in need for Christmas. - December 30, 2022 - Mako Medical Laboratories

First Overseas Shipment of CanSinoBIO’s Convidecia Air™ Delivered to Morocco

CanSino Biologics Inc. (“CanSinoBIO” or “the Company”) (SSE: 688185, HKEX: 06185) today announced that the first batch of its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation (trade name: Convidecia Air™) has arrived in Morocco, providing... - December 30, 2022 - CanSinoBIO

Creative Diagnostics Introduces Plaque Reduction Assay Service for Research Applications

Creative Diagnostics recently introduced Plaque Reduction Assay services to detect antibodies from testing serum and viruses within diseased materials to diagnose viral infectious diseases. - December 28, 2022 - Creative Diagnostics

Creative Diagnostics Launches Anti-Bacterial Antibodies to Support Autoimmune Diseases Research

Creative Diagnostics announced the launch of several mouse antibacterial monoclonal antibodies for the development of human and mouse anti-bacterial antibody detection kits. - December 28, 2022 - Creative Diagnostics

The Catholic Children’s Home Receives a Christmas Surprise

ProCare Health Embraces the Gift of Giving - December 23, 2022 - ProCare Health

Novel Melanoma Diagnostic Tool: MicroRNAs-Associated Extracellular Vesicles Endorsed by Creative Biolabs

Creative Biolabs identifies a suite of exosome services to advance basic research based on microRNAs-associated extracellular vesicles as novel diagnostic tools for melanoma. - December 21, 2022 - Creative Biolabs

Paras Biopharmaceuticals Creates Excellence with “Continuous Biomanufacturing”: Achieves Objectives of “High Productivity & Biomanufacturing Innovation”

Paras Biopharmaceuticals Creates Excellence with “Continuous Biomanufacturing”: Achieves Objectives of “High Productivity & Biomanufacturing Innovation”

With 6 years of dedicated work at Paras Biopharmaceuticals and the use of Paras Biopharmaceuticals’ unique technology platform (which comprises of Bioproduction technologies for economical production of biologics), the company is pleased to announce that an excellent scale-up production process is achieved with “Continuous Biomanufacturing.” - December 19, 2022 - Paras Biopharmaceuticals Finland Oy

The Updated iSpring Learn LMS Saves L&D Managers Hours Every Day While Boosting Their KPIs

The innovative features of iSpring Learn enables SMBs to boost training effectiveness by involving supervisors in training management, increasing employee engagement, and providing smarter event management. - December 12, 2022 - iSpring Solutions Inc.

Paras Biopharma Streamlines Offerings as “Biologics CDMO” and Biosimilar Co-Development as “Paras Biologics”

Paras Biopharma Streamlines Offerings as “Biologics CDMO” and Biosimilar Co-Development as “Paras Biologics”

Paras Biopharmaceuticals Finland Oy today revealed that the company has streamlined and enhanced its business activities with the establishment of a division called, Paras Biologics. In addition to its existing biologics CDMO activities and capabilities (this division is now referred to as Paras Biopharma), the creation of Paras Biologics enhances the company’s biologics and biosimilar pipeline for co-development and licensing opportunities. - December 11, 2022 - Paras Biopharmaceuticals Finland Oy

PharmStars Announces Fall 2022 Accelerator Graduates: 11 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program

PharmStars Announces Fall 2022 Accelerator Graduates: 11 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program

PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Fall 2022 program focused on “Innovations in Real-World Evidence.” The graduating startups successfully completed PharmaU, PharmStars’ 10-week education, and mentoring program. PharmaU culminated with a Showcase Event--held in Boston in early November--that brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - December 08, 2022 - PharmStars

Brooke Spicer Joins Sureguard LLC as Director of Operations

Brooke Spicer Joins Sureguard LLC as Director of Operations

The industry disrupting laboratory services company continues expansion to improve the experience of long-term care facilities. - December 08, 2022 - Sureguard LLC

IVL Creates New Supplement for Optimized Nitric Oxide Support and Better Blood Flow

IVL Creates New Supplement for Optimized Nitric Oxide Support and Better Blood Flow

4 ingredients to support the body's production of Nitric Oxide, a vital molecule for maintaining healthy muscles and blood vessels. - December 08, 2022 - IVL.com

CGO Group Support Foreign Investors in Adapting to Polish Tax and Accounting Regulations

CGO Legal has provided, over the years, legal support to more than 1500 Polish companies, mostly with a foreign ownership structure. The team consists of over 50 qualified experts, specializing in legal, taxation, and accounting fields. They support a new category of clients on the Polish legal... - December 06, 2022 - CGO Legal Chajdas Gawlak Owczarek sp. k.

PharmStars Announces “Innovations in Women’s Health and Health Equity” Theme for Spring 2023 Accelerator

PharmStars Announces “Innovations in Women’s Health and Health Equity” Theme for Spring 2023 Accelerator

PharmStars, the pharma-focused accelerator for digital health startups, is now accepting applications for its Spring 2023 cohort with the theme “Digital Innovations in Women’s Health and Health Equity.” Startups with digital innovations that promote more equitable, inclusive healthcare for underserved population or focused on women’s health (e.g., breast, ovarian, and cervical cancer; gynecological conditions; osteoporosis; menopausal, hormonal, and reproductive conditions) are welcome to apply. - December 05, 2022 - PharmStars

Clinical Research Organization, Huntington Study Group “Firsts” Continue

Clinical Research Organization, Huntington Study Group “Firsts” Continue

The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD) through its Clinical Research Organization (CRO), HSG Clinical Research, Inc. (HSGCR) continues making groundbreaking progress in the HD world. At their Annual Meeting in November, the... - December 05, 2022 - Huntington Study Group

Paras Biopharmaceuticals Finland Oy is Highly Recommended for Biologics CDMO – Development / Scale-up & Production of Biologics by Innovative USA Biopharma Company

Paras Biopharmaceuticals is pleased to announce that the company has been highly recommended for its Biologics CDMO – development / scale-up and production capabilities. The Paras Biopharmaceuticals Team has successfully completed multiple biologics projects in 2022. - November 29, 2022 - Paras Biopharmaceuticals Finland Oy

Huntington Study Group Annual Meeting

Huntington Study Group Annual Meeting

The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD), recently held its 29th Annual Meeting in Tampa, FL. This renowned meeting brings together HD thought leaders, scientific experts, industry partners and sponsors, advocacy groups, and... - November 29, 2022 - Huntington Study Group

Creative Diagnostics Introduces Hemagglutination Assay Service for Scientific Applications

Creative Diagnostics recently introduced Hemagglutination Assay services for influenza vaccine, diagnostic, and surveillance communities to measure virus and antibody titers and monitor influenza subtypes. - November 26, 2022 - Creative Diagnostics

Creative Diagnostics Announces New Polyethylene Glycol Antibodies Detection Kits

Creative Diagnostics announced the launch of a panel of anti-PEG IgG or IgM ELISA kits with different species reactivity to detect anti-PEG IgG or IgM in serum and plasma. - November 26, 2022 - Creative Diagnostics

Marty Rosenberg joins the Board of Scientific Advisors at Microvascular Therapeutics.

Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of Marty Rosenberg to the MVT Board of Scientific Advisors. Mr. Rosenberg brings a broad experience with the clinical development and global regulatory approval process for... - November 25, 2022 - Microvascular Therapeutics, Inc.

David Lim Joins the Team at Microvascular Therapeutics as Director of Finance

Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of David Lim as Director of Finance at MVT. Mr. Lim brings a broad experience with the business development and strategic financing for diagnostic pharmaceuticals across all... - November 25, 2022 - Microvascular Therapeutics, Inc.

Morgan County Medical Oncology Practices Combine to Provide Comprehensive Cancer Care

Morgan County Medical Oncology Practices Combine to Provide Comprehensive Cancer Care

Cancer Care Center of Decatur is joining Clearview Cancer Institute. CCI welcomes Dr. Naveen Lobo. - November 23, 2022 - Clearview Cancer Institute

Novugen Pharma Became the First Pharmaceutical Company in Malaysia to Receive USFDA Approval for Its Manufacturing Facility

Novugen Pharma Became the First Pharmaceutical Company in Malaysia to Receive USFDA Approval for Its Manufacturing Facility

The Company was audited in September 2022 and USFDA issued an Establishment Inspection Report (EIR) in November 2022. Novugen Pharma is the first USFDA approved pharmaceutical manufacturing in Malaysia and the only in Southeast Asia. - November 22, 2022 - Novugen

Introducing MIRAPeel MD, the Only 6-in-1 Clinical-Grade Skincare Platform of Its Kind

Introducing MIRAPeel MD, the Only 6-in-1 Clinical-Grade Skincare Platform of Its Kind

Attention Dermatologists, Plastic Surgeons and Med Spa Owners: Meet MIRAPeel MD, the one stop shop for all skin needs, and the first of its kind. Offering 6 treatments in one, MIRAPeel MD is setting a new treatment standard for skin care specialists, medical spas, dermatology and plastic surgery offices. - November 22, 2022 - eMIRAmed

Press Releases 351 - 400 of 8,731